These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31260502)

  • 1. Implementation of latent tuberculosis infection screening and treatment among newly arriving immigrants in the Netherlands: A mixed methods pilot evaluation.
    Spruijt I; Erkens C; Suurmond J; Huisman E; Koenders M; Kouw P; Toumanian S; Cobelens F; van den Hof S
    PLoS One; 2019; 14(7):e0219252. PubMed ID: 31260502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
    Campbell JR; Krot J; Elwood K; Cook V; Marra F
    Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study.
    Winje BA; Grøneng GM; White RA; Akre P; Aavitsland P; Heldal E
    BMJ Open; 2019 Jan; 9(1):e023412. PubMed ID: 30782706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Tuberculosis Among Immigrants in Korea Who Participated in a Latent Tuberculosis Infection Screening Program.
    Lee YJ; Min J; Myong JP; Lee YH; Park YJ; Kim Y; Kim G; Park G; Lee SS; Park JS; Kim JS; Kim HW
    J Korean Med Sci; 2024 Jul; 39(28):e207. PubMed ID: 39048302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intention of physicians to implement guidelines for screening and treatment of latent tuberculosis infection in HIV-infected patients in The Netherlands: a mixed-method design.
    Evenblij K; Verbon A; van Leth F
    BMC Public Health; 2016 Sep; 16(1):915. PubMed ID: 27585867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study.
    Spruijt I; Tesfay Haile D; Suurmond J; van den Hof S; Koenders M; Kouw P; van Noort N; Toumanian S; Cobelens F; Goosen S; Erkens C
    Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31537698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
    Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
    Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program: a community-engaged, mixed methods study among Eritreans.
    Spruijt I; Haile DT; Erkens C; van den Hof S; Goosen S; Ten Kate A; Teshome H; Karels M; Koenders M; Suurmond J
    BMC Public Health; 2020 Mar; 20(1):315. PubMed ID: 32164637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing tuberculosis screening for immigrants in southern New Brunswick: A pilot study protocol.
    Shamputa IC; Nguyen DTK; Higazy D; Abdelhadi A; MacKenzie H; Reddin M; Barker K; Webster D
    PLoS One; 2022; 17(11):e0277255. PubMed ID: 36331954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
    Haukaas FS; Arnesen TM; Winje BA; Aas E
    Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study.
    Ronald LA; Campbell JR; Rose C; Balshaw R; Romanowski K; Roth DZ; Marra F; Schwartzman K; Cook VJ; Johnston JC
    Clin Infect Dis; 2019 Nov; 69(12):2101-2108. PubMed ID: 30856258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions.
    Villa S; Codecasa LR; Faccini M; Pontello MM; Ferrarese M; Castellotti PF; Senatore S; Lamberti A; Mazzola E; Perno CF; Campisi D; Saporiti M; Raviglione MC
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31413161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.
    Marx FM; Hauer B; Menzies NA; Haas W; Perumal N
    BMC Public Health; 2021 Nov; 21(1):2172. PubMed ID: 34836526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postarrival Tuberculosis Screening of High-Risk Immigrants at a Local Health Department.
    Nuzzo JB; Golub JE; Chaulk P; Shah M
    Am J Public Health; 2015 Jul; 105(7):1432-8. PubMed ID: 25602872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent tuberculosis infection: screening and treatment in an urban setting.
    Morano JP; Walton MR; Zelenev A; Bruce RD; Altice FL
    J Community Health; 2013 Oct; 38(5):941-50. PubMed ID: 23728822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
    Getahun H; Matteelli A; Abubakar I; Aziz MA; Baddeley A; Barreira D; Den Boon S; Borroto Gutierrez SM; Bruchfeld J; Burhan E; Cavalcante S; Cedillos R; Chaisson R; Chee CB; Chesire L; Corbett E; Dara M; Denholm J; de Vries G; Falzon D; Ford N; Gale-Rowe M; Gilpin C; Girardi E; Go UY; Govindasamy D; D Grant A; Grzemska M; Harris R; Horsburgh CR; Ismayilov A; Jaramillo E; Kik S; Kranzer K; Lienhardt C; LoBue P; Lönnroth K; Marks G; Menzies D; Migliori GB; Mosca D; Mukadi YD; Mwinga A; Nelson L; Nishikiori N; Oordt-Speets A; Rangaka MX; Reis A; Rotz L; Sandgren A; Sañé Schepisi M; Schünemann HJ; Sharma SK; Sotgiu G; Stagg HR; Sterling TR; Tayeb T; Uplekar M; van der Werf MJ; Vandevelde W; van Kessel F; van't Hoog A; Varma JK; Vezhnina N; Voniatis C; Vonk Noordegraaf-Schouten M; Weil D; Weyer K; Wilkinson RJ; Yoshiyama T; Zellweger JP; Raviglione M
    Eur Respir J; 2015 Dec; 46(6):1563-76. PubMed ID: 26405286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prevalence of Latent Tuberculosis Infection in the United States.
    Mancuso JD; Diffenderfer JM; Ghassemieh BJ; Horne DJ; Kao TC
    Am J Respir Crit Care Med; 2016 Aug; 194(4):501-9. PubMed ID: 26866439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of and risk factors associated with latent tuberculosis in Singapore: A cross-sectional survey.
    Yap P; Tan KHX; Lim WY; Barkham T; Tan LWL; Chen MI; Wang YT; Chee CBE
    Int J Infect Dis; 2018 Jul; 72():55-62. PubMed ID: 29758278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preventing TB among immigrants; aiming for an integrated approach to infectious diseases].
    Erkens C; Spruijt I; van den Hof S
    Ned Tijdschr Geneeskd; 2020 Jul; 164():. PubMed ID: 32757512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of nurse-managed latent tuberculous infection treatment among hard-to-reach immigrants in Israel.
    Bishara H; Ore L; Vinitsky O; Bshara H; Armaly N; Weiler-Ravell D
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):799-804. PubMed ID: 26056104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.